These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15983919)
21. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations. Pinheiro Edos S; Antunes OA; Fortunak JM Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246 [TBL] [Abstract][Full Text] [Related]
29. Are we in it for the long haul? Gonsalves G GMHC Treat Issues; 2005; 19(3-4):16. PubMed ID: 16003846 [No Abstract] [Full Text] [Related]
30. Sustaining treatment costs: who will pay? Zewdie D; De Cock K; Piot P AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744 [No Abstract] [Full Text] [Related]
31. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Neuman MG; Monteiro M; Rehm J Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989 [TBL] [Abstract][Full Text] [Related]
32. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology of antiretroviral resistance and impact on treatment outcomes. Cane P J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892 [No Abstract] [Full Text] [Related]
34. Improvements in antiretroviral therapy outcomes over calendar time. Boyd MA Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050 [TBL] [Abstract][Full Text] [Related]
35. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008). Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB; J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643 [No Abstract] [Full Text] [Related]
36. The effects of antiretroviral therapy on HIV prevalence in conflict situations: not yet there. Spiegel PB AIDS; 2009 Feb; 23(4):541-2. PubMed ID: 19240460 [No Abstract] [Full Text] [Related]
37. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience. Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752 [TBL] [Abstract][Full Text] [Related]
38. Inequalities in health: access to treatment for HIV/AIDS. Giuliano M; Vella S Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264 [TBL] [Abstract][Full Text] [Related]
39. HIV/AIDS. The great funding surge. Cohen J Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876 [No Abstract] [Full Text] [Related]
40. A record 6.6 million patients in poor countries received antiretroviral treatment in 2010. Zarocostas J BMJ; 2011 Jun; 342():d3555. PubMed ID: 21646311 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]